Significance
Neurotrophins (NTs) are homodimeric growth factors displaying fundamental roles in the nervous system. Their activity stems from binding and activation of 3 different receptor types in nervous cell membranes. The p75 NT receptor (p75NTR) was the first to be discovered in 1986; nevertheless, for the numerous structural and functional facets so far reported, its activation mechanisms have remained elusive. Here, we demonstrate that its pleiotropic functions are regulated by different redistributions of the receptors, which crucially depend on the available NT and on the involved subcellular compartment but are unrelated to its oligomerization state. Single-particle studies proved receptors to be monomers with a fast-diffusive behavior in the membrane with, at most, transient self-interactions on the millisecond time scale.
Keywords: p75 neurotrophin receptor, membrane oligomeric state, single-molecule microscopy, apoptosis, growth cone collapse
Abstract
The p75 neurotrophin (NT) receptor (p75NTR) plays a crucial role in balancing survival-versus-death decisions in the nervous system. Yet, despite 2 decades of structural and biochemical studies, a comprehensive, accepted model for p75NTR activation by NT ligands is still missing. Here, we present a single-molecule study of membrane p75NTR in living cells, demonstrating that the vast majority of receptors are monomers before and after NT activation. Interestingly, the stoichiometry and diffusion properties of the wild-type (wt) p75NTR are almost identical to those of a receptor mutant lacking residues previously believed to induce oligomerization. The wt p75NTR and mutated (mut) p75NTR differ in their partitioning in cholesterol-rich membrane regions upon nerve growth factor (NGF) stimulation: We argue that this is the origin of the ability of wt p75NTR , but not of mut p75NTR, to mediate immature NT (proNT)-induced apoptosis. Both p75NTR forms support proNT-induced growth cone retraction: We show that receptor surface accumulation is the driving force for cone collapse. Overall, our data unveil the multifaceted activity of the p75NTR monomer and let us provide a coherent interpretative frame of existing conflicting data in the literature.
The p75 neurotrophin (NT) receptor (p75NTR) is a single-pass transmembrane (TM) receptor of the tumor necrosis factor (TNF) receptor superfamily (1). Along with the Trk tyrosine kinase receptor (2) and the Vps10p domain-sorting receptor families (3), p75NTR binds and is activated by NTs, small secreted homodimeric growth factors. NTs regulate survival, differentiation, and specification in developing neurons and plasticity and maintenance in adult neurons (4). This paradigmatic signaling system finely orchestrates 2 opposite pathways—survival versus death—in the central and peripheral nervous systems, and its alterations have a causal role in neurodegeneration (5, 6). Notably, p75NTR is the only NT receptor with significant binding affinity for all NTs, as well as for their respective immature forms (proNTs) (1), thus playing a central role in their balance. The p75NTR has long been considered a pan-NT coreceptor of Trk receptors, cooperating in the formation of high-affinity binding sites for NTs (7). However, the predicted ternary complex between NTs, Trk (or sorting receptors), and p75NTR has never been observed with structural biology techniques, and the available crystal structures of the nerve growth factor (NGF)-TrkA (8) [and NGF-SorC2 (9)], NT–p75NTR binary complexes have opposite orientations: This casts doubts on how a ternary complex could assemble (10). Available NT-p75NTR structures are conflicting per se, as the NGF-p75NTR cocrystal has 2:1 stoichiometry (11), while the NT3-p75NTR cocrystal has 2:2 stoichiometry (12), with no obvious rationale for their difference. In addition, p75NTR binds a number of ligands unrelated to NTs and has independent functions from Trks in controlling neurite outgrowth and morphology (13, 14), cell cycle withdrawal of developing neural progenitors (15), and viral-related neuropathies (16). It is thus clear that the structural basis of p75NTR signaling still needs proper understanding. On the basis of Western blot analysis from cell lysates, it was proposed that p75NTR acts as a preformed disulfide-linked dimer via a conserved TM cysteine residue (Cys256 in human numbering, employed throughout this paper, corresponding to residues 257 in rat and 259 in mouse numberings), which would act as a fulcrum to propagate a conformational change from the p75NTR extra- to intracellular domain upon NT binding (17). Cys256 mutation abolished NT-dependent apoptotic activity in cultured neurons and in a knock-in mouse model (18); however, this model was recently challenged by the report that this propagation of conformational changes could not be supported by the flexible p75NTR juxtamembrane (JM) intracellular region (19). Furthermore, a similar Western blot analysis performed by Anastasia et al. (20) showed the existence of p75NTR trimers, which are more represented than dimers; oligomerization, however, was not necessary for proNGF-induced growth cone collapse in developing neurons (20).
Here, we directly and quantitatively assess p75NTR oligomerization status in the plasma membrane of living cells by means of single-molecule fluorescence microscopy with a minimally invasive strategy (21, 22); this relies on insertion of a short peptide tag in the p75NTR protein and its labeling with 1:1 stoichiometry (23, 24). This method also allows imaging the receptor with small organic dyes, which, unlike the more cumbersome Quantum dots (Qdot), permits one to retrieve the receptor oligomeric state from their fluorescent intensity (21). We show that membrane p75NTR is mostly a fast-diffusing monomer, regardless of NT stimulation. Its self-interactions are far too transient to result in substantial receptor di- or trimerization; importantly, they do not depend on Cys256 or on other residues previously suggested to play a role in receptor oligomerization. We also gather evidence on why the p75NTR C256A mutant does not elicit NT-dependent apoptosis (18) but is functional for growth cone collapse signaling (20). By solving this apparent contradiction, we revisit here p75NTR function, in the conceptual framework of a versatile monomeric receptor.
Results
Expression, Validation, and Membrane Fluorolabeling of Human p75NTR Constructs.
We previously demonstrated that p75NTR can be enzymatically labeled with small chemical probes (e.g., biotin, organic fluorophores) in a site-specific way, inserting 12 amino acid-long tags of the ACP/PCP family at its N terminus (23). This allows a covalent modification with 1:1 stoichiometry (i.e., 1 probe per p75NTR molecule) of the receptors exposed on the surface of living cells (24, 25). Here, we used S6-p75NTR (Fig. 1A) for its better labeling performance when compared with A1-p75NTR (SI Appendix, Fig. S1). We found that S6-p75NTR correctly localizes on the plasma membrane, as well as on intracellular structures like the nuclear envelope, similar to endogenous p75NTR expressed by PC12 cells (26) (Fig. 1B). Like endogenous p75NTR (SI Appendix, Fig. S2), S6-p75NTR undergoes palmitoylation (Fig. 1C), an important posttranslational modification for p75NTR death domain signaling capability (27). The p75NTR was recently reported to localize asymmetrically in neurons, helping in specifying the future axon (28); accordingly, biotinylated S6-p75NTR receptors preferentially localize in neurites and growth cones in developing hippocampal neurons (Fig. 1D). Furthermore, S6-p75NTR–EGFP was able to induce growth cone collapse in the same neurons upon proNGF administration (Fig. 1E), as reported for previous p75NTR constructs devoid of chemical tags (29). Finally, proBDNF binding to p75NTR was recently reported to increase the number of apoptotic neurons (18) (Fig. 1F, Top). By transducing S6-p75NTR in cortical neurons from p75NTR knockout (KO) mice (30) with an inducible lentiviral vector (24), we found that it was able to recapitulate proBDNF-induced apoptosis (Fig. 1F, Middle and Bottom). The lower percentage of apoptotic neurons, with respect to that raised by endogenous p75NTR, is likely due to the presence of untransduced neurons.
Overall, our data demonstrate that the S6-tagged construct of human p75NTR retains the properties of endogenous p75NTR. We therefore employed it to visualize the p75NTR membrane pool in living cells and to describe its behavior in a direct, unperturbed physiological way.
p75NTR Single Molecules Diffuse as Monomers in the Cell Membrane.
We first sought to investigate the membrane p75NTR diffusive properties and oligomerization state in living cells. To this end, we expressed S6-p75NTR in neuroblastoma SK-N-BE(2) cells, a line that conceivably models a neuronal membrane with the advantage of lacking endogenous p75NTR and TrkA at both messenger RNA and protein levels (31). Once labeled with Abberior635P dye (SI Appendix, Fig. S3), S6-p75NTR imaged with total internal reflection fluorescence (TIRF) microscopy appears as a carpet of spots decorating the cell basal membrane, each corresponding to a single receptor particle (Fig. 2 A and B). With a Tet-On inducible promoter (24), we tuned receptor expression from low (∼0.1 spot per square micrometer) to the highest density allowing us to track p75NTR receptors individually (∼0.5 spot per square micrometer), and even to bulk p75NTR expression (Fig. 2A). Receptors at densities from 0.1 to 0.45 spot per square micrometer were followed over time (Movies S1 and S2), and tracked at the single-particle level (32) (Fig. 2B and Movie S3). We compared wild-type p75NTR (wt p75NTR; Fig. 2C) with 2 reference monomeric or dimeric variants of S6-tagged p75NTR. The “monomeric” form contains C256A and G265I mutations on the p75NTR TM domain, which were reported to inhibit covalent and noncovalent receptor dimerization, respectively (17), along with a deletion in its JM region that inhibits intracellular clustering (33) (mutant p75NTR [mut p75NTR]; Fig. 2C). The mut p75NTR recapitulated the localization observed for wt p75NTR (SI Appendix, Fig. S4 A and B); importantly, it did not display the high-molecular-weight bands in Western blots (SI Appendix, Fig. S4C) previously identified as putative receptor oligomeric forms (17, 20). To force dimerization, we replaced the entire wt p75NTR extracellular JM region with the c-jun leucine-zipper domain, as in a study by Brooks et al. (34) (dim p75NTR; Fig. 2C).
In SK-N-BE(2) cells, analysis of the short-time diffusion coefficient (D) distributions, as in studies by Marchetti et al. (21) and Callegari et al. (25), revealed that wt p75NTR and mut p75NTR are indistinguishable, while dim p75NTR is significantly slower, showing a distribution shifted toward D values compatible with what is expected for dimers (35) and a somewhat higher low-D tail (Fig. 2D); these data suggest the absence of stable dimers for both wt p75NTR and mut p75NTR. To identify possible transient p75NTR dimers, we analyzed the dynamic association/dissociation of spots during their trajectories (merge and split [M&S] events, shown in Movies S4 and S5 and schematized in Fig. 2F), as previously done by Kasai and Kusumi (36). The number of M&S events per membrane area was significantly lower for dim p75NTR than for wt p75NTR and mut p75NTR; the latter 2, instead, did not differ significantly (Fig. 2E). This shows that the 3 p75NTR constructs display an observable dynamic equilibrium between monomers and dimers, but while wt p75NTR has association/dissociation kinetics similar to mut p75NTR, dim p75NTR has either a higher dimerization probability or a lower separation rate. We also quantified the mean duration of transient dimerization (Td) events (orange in Fig. 2F), i.e., the trajectory segments between a merge event and a split event. The distribution of average Td lifetime demonstrated that while wt p75NTR and mut p75NTR display dimerization events equally peaked between 0.4 and 0.5 s, those of dim p75NTR peak at 0.6 and 0.8 s (Fig. 2G). These results allow us to determine that wt p75NTR does not form stable dimers or higher oligomers in the living cell membrane.
Because of the transient nature of p75NTR dimers, as well as of photobleaching during tracking, analysis of the average intensity of the trajectories in live cells could not give an unambiguous answer on the stoichiometry (SI Appendix, Fig. S5). Therefore, we analyzed the intensity step photobleaching profile of isolated p75NTR/Abberior635P spots in fixed cells (yellow boxes in Fig. 3A). For each spot, we quantified 1) the number of photobleaching steps (red arrows in Fig. 3B) and 2) the mean intensity before bleaching (IPRE; green lines in Fig. 3B). Both constitute a direct measure of the number of molecules in a spot for receptor membrane oligomerization (37). The vast majority of analyzed wt p75NTR and mut p75NTR spots are monomers; that is, they display 1 photobleaching step (about 77% for both species; Fig. 3C). Conversely, the NGF-stimulated S6-TrkA construct displayed a significantly higher proportion of dimers and oligomers (26) (SI Appendix, Fig. S6A). Importantly, the majority of dim p75NTR spots showed a 2-step photobleaching profile (55%; Fig. 3C), and monomers were reduced to 35%. Only dim p75NTR displayed a sizeable amount of spots with 3 and 4 photobleaching steps. IPRE distributions obtained for the 3 p75NTR variants confirmed the bleaching step analysis (SI Appendix, Fig. S6B).
We underline that some mut p75NTR apparent dimers were detected (about 20% of the analyzed spots) similar to wt p75NTR: This proves the lack of a relationship with the TM residues previously indicated as driving receptor dimerization (17). Overall, our experiments distinguish between the diffusivity of monomers and dimers, and challenge the existence of stable p75NTR dimers in the membrane of live cells.
wt p75NTR and mut p75NTR Display Different Membrane Partitioning in Response to NGF Stimulation.
We next compared wt p75NTR and mut p75NTR membrane diffusivity following NT stimulation, to see if this might impact the oligomeric state of the receptor. Also, we aimed at identifying a possible molecular basis, an alternative to the lack of oligomerization, as the source of the impaired apoptotic signaling of mut p75NTR following NT stimulation (17, 18).
We measured D values from trajectories of wt p75NTR and mut p75NTR with or without 15 min of NGF stimulation. The diffusivity of both constructs upon NGF treatment remained significantly higher than that of the dim p75NTR construct (Fig. 4A). This suggests that NGF does not induce dimerization of either construct. These data are consistent with the absence of fluorescence resonance energy transfer (FRET) or homo-FRET changes following NT addition in cells expressing fluorescent p75NTR constructs (17, 38). However, NGF elicits a small but statistically significant shift of D distributions of the 2 constructs in opposite directions (i.e., it slightly slows down wt p75NTR, while it speeds up mut p75NTR). Similarly, a slowing down of wt p75NTR was observed in proNGF-treated neurons (SI Appendix, Fig. S7). Since these changes are not compatible with gain or loss of stable oligomerization, we reasoned that they might stem from wt p75NTR and mut p75NTR movements across membrane areas with different composition. In this scenario, lipid rafts may represent the discriminating factor, as they could confine and alter transiently the diffusivity of membrane proteins (39). Cholesterol plays a key structural role in lipid rafts, and the association of proteins with lipid rafts can be detected experimentally by testing cholesterol-dependent, confined diffusion (40). Consistently with this, p75NTR mobility was found to depend on the cholesterol content in the plasma membrane (41), and we measured a clear anticorrelation between its D value and membrane cholesterol in 6 cellular models (Fig. 4B and SI Appendix, Fig. S8). The fastest p75NTR diffusivity is observed in cortical neurons, which display the lowest membrane cholesterol levels of our survey; SK-N-BE(2) cells have a cholesterol content similar to neurons, thus validating the choice of this model system to study p75NTR membrane dynamics.
Given that raft domains are crucial for apoptotic signaling via p75NTR (42), we considered that differential residency of wt p75NTR and mut p75NTR upon NT binding in these areas might explain not only the D changes observed (Fig. 4A) but also their different signaling abilities. To test this hypothesis, we first monitored NGF-driven diffusivity of the 2 receptor forms following up- or down-regulation of membrane cholesterol in SK-N-BE(2) cells (Fig. 4C). While increasing membrane cholesterol slows down both receptor forms, removal of membrane cholesterol has 2 opposite outcomes: wt p75NTR is accelerated, while mut p75NTR slowed (Fig. 4D). Since the effect of cholesterol depletion on lateral diffusion depends on the composition of the membrane regions explored by the membrane receptors (43), these data suggest that wt p75NTR and mut p75NTR partition into different membrane areas after NGF binding. These relocalizations most probably occur in a very dynamic way, given the small diffusivity changes involved (Fig. 4A and SI Appendix, Fig. S7). Indeed, biochemical isolation of raft domains showed wt p75NTR localizing in both raft and nonraft regions, in the absence and presence of NGF (44, 45). Thus, to capture transient raft occupancy, we imaged lipid rafts and p75NTR simultaneously, after 15 min of NGF stimulation, by dual-color TIRF microscopy (Fig. 4E), similar to the method used by Pinaud et al (46). Rafts were visualized by cross-linking membrane ganglioside GM1 with a fluorescent cholera toxin B subunit (47). NGF stimulation significantly increases the localization of wt p75NTR in GM1 regions, but not that of mut p75NTR (Fig. 4F).
We conclude that p75NTR translocates to lipid rafts upon NGF binding, and mut p75NTR has a reduced residency in cholesterol-rich membrane microdomains upon NGF binding compared with the wt counterpart. Notably, in the absence of competing Trk receptors, both NTs and proNTs induce coherent effects on p75NTR in terms of both membrane diffusivity (Fig. 4A and SI Appendix, Fig. S7) and biological activity; for instance, proBDNF induces apoptosis via p75NTR (18), but p75NTR also mediates apoptosis in retinal neurons by NGF (48) and in sympathetic neurons by BDNF (49).
Membrane Cholesterol Regulates p75NTR Apoptotic Signaling.
Following previous observations, we tested if membrane cholesterol levels also affected NT-dependent apoptotic signaling via p75NTR; here, C256 TM residue was shown to play a crucial role (17, 18). Treating neurons with mevastatin and methyl-beta-cyclodextrin (MβCD) strongly decreases membrane cholesterol, as measured by filipin staining, while loading neurons with cholesterol has the opposite effect (Fig. 5 A and B). The proBDNF-induced apoptosis was abolished in cholesterol-depleted cortical neurons from wt mice, while it was slightly increased upon cholesterol overload (Fig. 5C). Cholesterol modulation was also applied to wt p75NTR and mut p75NTR (Fig. 5 D–F) transduced in p75NTR KO mouse neurons and induced with 0.05 μg/mL doxycycline, a concentration not leading to overexpression (Fig. 2A). The p75NTR KO neurons were not responsive to proBDNF; wt p75NTR, but not mut p75NTR, restored proapoptotic signaling (Fig. 5D). When neurons were treated with mevastatin/MβCD, wt p75NTR lost its ability to induce apoptosis, confirming our results on wt neurons (Fig. 5 C and E). Conversely, cholesterol administration boosted proapoptotic signaling of wt p75NTR (Fig. 5 F and G); surprisingly, the same treatment also conferred apoptotic capability to mut p75NTR (Fig. 5 F and G). This was not an effect of the combination of proBDNF and cholesterol load: Untransduced neurons from p75NTR KO mice were not responsive in these conditions (Fig. 5F).
From these results, we conclude that the inability of mut p75NTR to induce apoptosis (18) (Fig. 5D) is due to its poorer occupancy of cholesterol-rich membrane regions when compared with wt p75NTR, rather than to impaired signaling of the protein per se. Accordingly, under membrane-saturating conditions obtained inducing p75NTR expression with 1 μg/mL doxycycline (Fig. 2A), both mut p75NTR and wt p75NTR were able to induce apoptosis (SI Appendix, Fig. S9). These findings, along with those obtained in SK-N-BE(2) cells (Fig. 4), show that NT binding regulates the partitioning of p75NTR in and out of lipid rafts, thereby regulating its ability to induce apoptosis.
Surface-Exposed p75NTR Mediates Growth Cone Collapse in the Presence and Absence of proNGF.
Growth cone retraction caused by overexpression of both wt p75NTR and a C256A p75NTR mutant was reported to occur upon proNGF administration in developing neurons (20). Hence, p75NTR collapse action may not necessarily depend on receptor partitioning in cholesterol-rich regions, unlike apoptotic signaling (Fig. 5). We therefore investigated the mechanisms of axonal growth regulation by p75NTR. We found that endogenous levels of p75NTR can also regulate axon branching. Axonal arbors of CA3 neurons projecting into the CA1 region are significantly more ramified and occupy larger areas in p75NTR KO mice than in wt mice (SI Appendix, Fig. S10 A and B). This is reflected in a higher number of synaptic boutons (SI Appendix, Fig. S10C), consistent with previous observations of p75NTR KO animals showing increased dendritic complexity (50). Neuronal cultures of the same animals recapitulated this result (Fig. 6 A and B), with p75NTR KO axons being longer (Fig. 6C) and displaying an increased number of branch points (Fig. 6D) and lateral growth cones per length unit (Fig. 6E) with respect to wt axons. Importantly, transient expression of wt p75NTR or mut p75NTR constructs in p75NTR KO neurons completely rescued the phenotype observed in wt neurons (Fig. 6 C–E). In agreement with previous data (20), expression of either wt p75NTR or mut p75NTR in hippocampal neurons leads to growth cone collapse in response to proNGF (SI Appendix, Fig. S11 A and B). Overall, this suggests that the regulation of axonal complexity and proNT-dependent collapse of growth cones share a common mechanism regulated by p75NTR independently on Cys256 and other residues mutated or missing in mut p75NTR (Fig. 2C).
To gain further insight into this mechanism, we monitored the membrane pool of S6-p75NTR–EGFP during collapse by biotinylating the receptors on the cell surface before proNGF incubation, and detecting receptors still present on the plasma membrane with streptavidin-Qdot after proNGF incubation for 30 min; EGFP fluorescence marked the total content of p75NTR (Fig. 7A). The proNGF caused a dramatic increase in the membrane pool of both wt p75NTR and mut p75NTR, while lower levels of membrane p75NTR were detected in untreated neurons (Fig. 7 B and C). Inhibition of dynamin-dependent internalization with Dynasore (Fig. 7D), to maintain wt and mut S6-p75NTR–EGFP on the surface regardless of proNGF administration (Fig. 7E), was sufficient to drive the growth cone collapse, independently from ligands; indeed, proNGF had no further collapse-inducing effect, implying that p75NTR exposure is a downstream event to ligand binding (Fig. 7F and SI Appendix, Fig. S11A). Notably, Dynasore alone in untransfected neurons did not have such a prominent effect, although a trend could be observed upon drug treatment and proNGF administration (Fig. 7F); this is likely due to a fraction of hippocampal neurons expressing detectable levels of p75NTR, as previously shown (29). Inhibiting p75NTR internalization by expressing the K44A dominant negative form of dynamin had the same effect (SI Appendix, Fig. S11 D and E), confirming the results obtained with Dynasore. Furthermore, we found that the mechanism responsible for the removal of p75NTR from the plasma membrane in the absence of proNGF is dependent on clathrin, as blocking clathrin-dependent endocytosis by Pitstop2 was sufficient to accumulate surface p75NTR and trigger neuronal growth cone collapse (Fig. 7 G–J).
These data suggest that p75NTR has an intrinsic collapsing activity when retained on the growth cone membrane, and internalization inhibition is a sufficient driving force that does not necessarily require NT-induced partitioning into raft domains. Indeed, both wt p75NTR and mut p75NTR constructs similarly regulate axonal complexity. Overexpression has been called into question in the evaluation of growth cone collapse (18). Indeed, p75NTR expression by a constitutively strong promoter results in a many-fold expression increase compared with that of p75NTR induced at 0.05 μg/mL doxycycline (SI Appendix, Fig. S12), which recapitulates the behavior of endogenous p75NTR (Fig. 5). We therefore evaluated the effect of proNGF on neurons infected with wt p75NTR or mut p75NTR and induced with 0.05 μg/mL or 1 μg/mL doxycycline (SI Appendix, Fig. S13A). We found that growth cone collapse could still be observed, although at lower levels than with overexpressed p75NTR. The growth cone area decreases with increasing surface p75NTR density: In particular, a threshold for growth cone collapse was found in the range of 1 to 2 receptors per square micrometer (SI Appendix, Fig. S13 B and C). Although slightly higher than the receptor ranges explored in our advanced imaging (Fig. 3 and SI Appendix, Fig. S7) and apoptosis assays (Fig. 5), this value seems compatible with physiological levels observed at least in a subset of central neurons displaying sufficient p75NTR levels to drive cone retraction (29). At 0.05 μg/mL doxycycline, p75NTR explores a range of expression levels on the neuronal surface, with densities spanning from below to above the range of 1 to 2 receptors per square micrometer, and this explains why only a subpopulation of neurons undergoes growth cone collapse in this sample (SI Appendix, Fig. S13). Importantly, the growth cone area distribution for mut p75NTR neurons was not significantly different from that for wt p75NTR, and the 2 forms displayed similar area versus p75NTR level dependency (SI Appendix, Fig. S13C), thus ruling out overexpression as the cause for their identical behavior (Fig. 6). This demonstrates that growth cone collapse via p75NTR can occur at receptor levels close to or slightly higher than the natural average density in neurons, and that both p75NTR forms are equally capable of mediating it.
Discussion
To solve the oligomerization conundrum of p75NTR in a live cell context and to gain insight into its mechanisms of activation by NTs, we applied a single-molecule fluorescence approach that we had already validated to image and track NT receptors and their ligands (21–25). This avoids the use of indirect methods like labeled antibodies or ligands and obviates the problem of Qdot steric hindrance (51) (SI Appendix, Fig. S3). In neuroblastoma cells (Movie S1 and Figs. 2D and 4A), as well as in primary neurons (Fig. 4B, SI Appendix, Fig. S7, and Movie S2), p75NTR exhibits fast dynamics and is mostly present in monomeric form. NT or proNT stimulations do not alter its stoichiometry significantly (Figs. 3 and 4A); instead, our data show that p75NTR molecules only form transient homointeractions if any (Figs. 2 E–G and 3), indicating that dynamic interactions are likely to underlie receptor activation.
The existence of preformed p75NTR oligomers in the membrane has been hotly debated, with different groups reporting p75NTR dimers (1, 17), trimers (13), or a mixture of both (16, 20). Evidence for oligomerization mostly came from the electrophoretic shift of the immunodetected receptor band of 2- or 3-fold the weight of the monomer, in nonreducing conditions or after chemical cross-linking. However, this constitutes an indirect way of investigating stoichiometry. Indeed, both run length and intensity of higher weight bands in a gel critically depend on several technical parameters, such as lysis conditions, antibody, or composition of the gel (SI Appendix, Table S1 and compare, e.g., SI Appendix, Figs. S4 and S14). Heavier p75NTR-immunoreactive bands may be the result of p75NTR homo- or heteroaggregation with unknown proteins or lipids in close proximity. Indeed, p75NTR association with gangliosides in response to ligands was already reported (52). Thus, the shifted bands could simply reflect crowding of molecules interacting transiently in cholesterol-rich regions, which are stabilized by certain lysis conditions, rather than a stable physical association. This is supported by the recent observation that the putative oligomeric shifted band of another TNF receptor, Death Receptor 5, is impaired by cholesterol-depletion treatments (53). Here, we provide a direct and quantitative estimate of the human full-length p75NTR oligomerization state in the cell membrane. Our data on dynamics and bleaching steps demonstrate a predominant monomeric p75NTR form (∼77%; Fig. 3B). Notably, this percentage is almost identical (Fig. 3B), as is the diffusive profile (Fig. 2 D–G), to a reference monomeric p75NTR construct (mut p75NTR), which bears all mutations impairing p75NTR gel-shifted bands (17, 20, 33) (Fig. 2C). Therefore, even if ∼22% of p75NTR apparent dimers are detected, they are not dependent on the mutated or deleted residues; this fraction likely constitutes an overestimation due to nonresolved pairs of individual monomers merely in proximity, especially in small zones on the membrane where diffusivity is hindered; a similar effect could also explain the presence of trimers and tetramers for dim p75NTR. For G protein-coupled receptors, apparent oligomers were quantified to be a 3/6-fold overestimation in similar ranges of receptor densities (54).
Our dynamics data question the possibility of a covalent TM p75NTR dimerization, challenging a previous model for the p75NTR mechanism of action, which postulates that NT binding to the putative preformed p75NTR covalent dimer induces a conformational change propagated via Cys256, leading to separation of death domains (17). This model was already challenged by structural considerations on the flexibility of the JM and chopper domains (19). We propose an alternative molecular basis for receptor activation, in which p75NTR monomers preferentially concentrate into signaling-competent membrane microdomains, like lipid rafts, upon NGF stimulation, with C256 and G265 residues playing a crucial role in this compartmentalization (Fig. 8A). Indeed, the importance of Cys256 was corroborated by the failure of proBDNF-induced neuronal apoptosis in mut p75NTR knock-in mice (18). This is supported by the observation that wt (but not mut) p75NTR displays higher average residency in GM-1–rich regions upon NGF binding (Fig. 4 E and F), and that the diffusion of NGF-bound wt p75NTR and mut p75NTR displays different responses to cholesterol-modulation treatments (Fig. 4D).
Robust evidence correlates NT signaling, especially proapoptotic signaling, to the residency of NT receptors in lipid rafts, probably because many interactors and effectors of the pathway are commonly associated with these regions (42, 44, 55). Indeed, p75NTR palmitoylation (Fig. 1C) can mediate the association of the protein with lipid rafts (1), and is necessary for p75NTR proapoptotic activity (27). Hence, p75NTR may be capable of activating apoptosis in these zones only, and lack of proBDNF-induced apoptosis by mut p75NTR (Fig. 5D) can be explained by its inability to enter these regions upon NT binding (Fig. 8A). Our diffusivity data with cholesterol modulation also point to this interpretation (Fig. 4 C–F). It is unclear to us why the modifications of TM residues may impair the residency of p75NTR in lipid rafts. Available models (38) and NMR structures (56) of the p75NTR TM domain agree in not mapping the 2 residues on the same side of the TM helix. We speculate that these residues are involved in creating peculiar interfaces that bind specific lipids (possibly cholesterol itself) or proteic components of lipid rafts; in support of this, cholesterol depletion impaired proBDNF-induced apoptosis (Fig. 5E).
Despite their difference in apoptotic signaling, wt p75NTR and mut p75NTR are equally capable of mediating growth cone collapse in developing neurons (20) (SI Appendix, Fig. S11 A and B). Here, we showed that this effect is linked to the local concentration of the receptor on the growth cone surface. Although it was previously evaluated in p75NTR overexpression regimes (20, 29), we show here that it is still observed when p75NTR is ∼4- to 20-fold less expressed (SI Appendix, Fig. S12), thus falling in a range of concentrations compatible with the endogenous levels (SI Appendix, Fig. S13). This is particularly plausible if the observed polarized distribution of surface p75NTR is taken into account (Fig. 1D). The mechanism is likely to support collapse in a cone-autonomous way. Indeed, collapsed cones show higher levels of surface p75NTR than extended ones even within the same neuron (Fig. 7J). The p75NTR surface density is most probably controlled by removal from the plasma membrane and sequestration in intracellular stores. Acute proNGF administration increases both wt p75NTR and mut p75NTR surface pools at growth cones, and inhibition of p75NTR internalization mimics the proNT effect (Fig. 7 and SI Appendix, Fig. S11). Although we cannot tell whether proNGF prevents p75NTR internalization or increases p75NTR recycling onto the plasma membrane (Fig. 8B), we argue that a signaling cascade activated by surface-exposed p75NTR is responsible for growth cone retraction and axonal complexity. This mechanism could be activated by proNT binding, p75NTR local accumulation (28), or interactions with membrane partners like ephrin-A (57), eventually leading to Rac and RhoA activation (29, 58). It is also possible that p75NTR binds different proteins on the plasma membrane and intracellular stores, possibly regulating their availability. In any case, this activity is not dependent on the TM and JM residues mutated or missing in mut p75NTR, and therefore on the membrane partitioning necessary for proapoptotic signaling (Fig. 8). Accordingly, axonal extension and branching are enhanced in p75NTR KO hippocampal neurons (Fig. 6 A and B and SI Appendix, Fig. S10) and this enhancement is suppressed by either wt p75NTR or mut p75NTR expression (Fig. 6 C–E). These data corroborate the observation that sympathetic sprouting is enhanced in p75NTR-exIII and p75NTR-exIV KO mice (59). In addition, p75NTR-exIII and p75NTR-exIV KO neurons display increased dendritic complexity, and p75NTR-rich dendritic regions are particularly devoid of collateral branches (50).
In summary, our results demonstrate that p75NTR exists predominantly as a fast-diffusing monomer at the neuronal plasma membrane, and that its signaling capabilities depend on the membrane microdomains traversed and on the amount of surface-exposed receptor available in particular neuronal compartments. Interestingly, while this paper was in preparation, the existence of TrkB dimers was challenged by demonstrating that this receptor is mostly active as monomer on the plasma membrane: This posed severe doubts regarding a long-accepted view of TrkB dimerization as a key step in the transduction of BDNF signaling, partially supported by electrophoretic shifts after chemical cross-linking (60). A scenario emerges in which availability of NT receptor monomers is a fundamental step for signal transduction via Trk-NT-p75NTR constructs induced by the binding of clustered forms of NTs, as recently proposed based on structural data (61). It remains to be established, however, whether coexpression of Trks results in changes of the p75NTR oligomerization state in the cell plasma membrane. In any case, the multifaceted mechanisms of action of the p75NTR monomer suggested by our findings can successfully reconcile most of the apparently conflicting data reported in the literature for the structure and function of this pleiotropic receptor.
Material and Methods
Stoichiometry by Single-Molecule Step Photobleaching.
The wt p75NTR, mut p75NTR, and dim p75NTR constructs were transduced in SK-N-BE(2) cells, labeled with Abberior 635P and then fixed for 90 min at room temperature with 4% paraformaldehyde, 5% sucrose, and 0.1% glutaraldehyde in phosphate-buffered saline (PBS); washed 5 times with PBS; and imaged in PBS on the TIRF microscope. Three thousand-frame movies were acquired in a 32.68 × 32.68-μm region of interest centered on the selected cells, with 21 ms of integration time. Time series were then analyzed as described previously (37).
Cleaved Caspase-3 Assay.
Cortical neurons from wt p75NTR and p75NTR KO mice seeded on coverslips were left untreated or transduced with wt/mut p75NTR. On day in vitro 3 (DIV3), neurons were treated for 12 h with 20 ng/mL human proBDNF. Samples were then fixed in cold 1:1 acetone/methanol solution for 15 min at −20 °C and processed for immunofluorescence with anti–cleaved caspase-3 (1:300, 9664; Cell Signaling Technology) and anti–MAP-2 (1:2,500, M9942; Sigma–Aldrich) antibodies. Samples were imaged on a confocal microscope with a 20× air objective (numerical aperture = 0.5) and pinhole at 1.5 airy units. Cleaved caspase-3–positive neurons were defined as MAP2-positive cells displaying a mean intensity above an intensity threshold in the cleaved caspase-3 channel.
Growth Cone Collapse Assay.
Hippocampal neurons were transfected with S6-p75NTR–GFP constructs; alternatively, they were transduced with inducible wt p75NTR or mut p75NTR and induced at 0, 0.05, or 1 μg/mL doxycycline concentrations. On DIV3, p75NTR was biotinylated at the cell surface before incubation with 20 ng/mL proNGF. Neurons were then washed once and incubated with 10 nM streptavidin-Qdot655, washed 5 times, and fixed in 2% formaldehyde and 5% sucrose in PBS before confocal or TIRF imaging. To inhibit p75NTR endocytosis, the above experiment was repeated in the presence of 80 μM Dynasore (Sigma–Aldrich) or 25 μM Pitstop2 (Abcam). We measured 1) the area of all detectable growth cones; 2) for S6-p75NTR–EGFP constructs, the ratio between the Qdot and EGFP channels as a measure of membrane versus total receptor pool; and 3) for all p75NTR constructs, the intensities in the Qdot channel as a measure of membrane abundance at the different expression levels.
More details on material and methods appear in SI Appendix. Readers will be able to access codes and materials by directly contacting the corresponding authors.
Supplementary Material
Acknowledgments
We thank Robert Youker for the mut p75NTR construct; Luca Puzzi for the human c-jun complementary DNA, and Gianmichele Ratto for adeno-associated viral vectors for in vivo YFP expression. We thank Carmine Di Rienzo, Francesco Cardarelli, Marco Canossa, Beatrice Vignoli, Michela Serresi, and Andrea Palamidessi for useful discussions. This study was supported by funding from Tuscany Region, Project NOSEISMIC, within Grant POR CRO FSE 2007-2013 (to S.L.); Ministero Università e Ricerca Projects PRIN 2009XPTWM2 (to S.L.) and FIRB RBAP11X42L (to F. Beltram); Fondazione Pisa Project RST 148/16; European Union Paincage and H2020 Human Brain Projects (SGA1 and SGA2) (to A.C.); and Institutional Scuola Normale Superiore funds (to S.L., L.M., and A.C.).
Footnotes
The authors declare no conflict of interest.
This article is a PNAS Direct Submission.
See Commentary on page 21343.
This article contains supporting information online at www.pnas.org/lookup/suppl/doi:10.1073/pnas.1902790116/-/DCSupplemental.
References
- 1.Vilar M., “Structural characterization of the p75 neurotrophin receptor: A stranger in the TNFR superfamily” in Vitamins and Hormones, Litwack G, Ed. (Elsevier, 2017), vol. 104, pp. 57–87. [DOI] [PubMed] [Google Scholar]
- 2.Huang E. J., Reichardt L. F., Trk receptors: Roles in neuronal signal transduction. Annu. Rev. Biochem. 72, 609–642 (2003). [DOI] [PubMed] [Google Scholar]
- 3.Nykjaer A., Willnow T. E., Sortilin: A receptor to regulate neuronal viability and function. Trends Neurosci. 35, 261–270 (2012). [DOI] [PubMed] [Google Scholar]
- 4.Chao M. V., Neurotrophins and their receptors: A convergence point for many signalling pathways. Nat. Rev. Neurosci. 4, 299–309 (2003). [DOI] [PubMed] [Google Scholar]
- 5.Cattaneo A., Calissano P., Nerve growth factor and Alzheimer’s disease: New facts for an old hypothesis. Mol. Neurobiol. 46, 588–604 (2012). [DOI] [PubMed] [Google Scholar]
- 6.Chen X. Q., Sawa M., Mobley W. C., Dysregulation of neurotrophin signaling in the pathogenesis of Alzheimer disease and of Alzheimer disease in Down syndrome. Free Radic Biol. Med. 114, 52–61 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Hempstead B. L., Martin-Zanca D., Kaplan D. R., Parada L. F., Chao M. V., High-affinity NGF binding requires coexpression of the trk proto-oncogene and the low-affinity NGF receptor. Nature 350, 678–683 (1991). [DOI] [PubMed] [Google Scholar]
- 8.Wehrman T., et al. , Structural and mechanistic insights into nerve growth factor interactions with the TrkA and p75 receptors. Neuron 53, 25–38 (2007). [DOI] [PubMed] [Google Scholar]
- 9.Leloup N., Chataigner L. M. P., Janssen B. J. C., Structural insights into SorCS2-nerve growth factor complex formation. Nat. Commun. 9, 2979 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Barker P. A., High affinity not in the vicinity? Neuron 53, 1–4 (2007). [DOI] [PubMed] [Google Scholar]
- 11.He X. L., Garcia K. C., Structure of nerve growth factor complexed with the shared neurotrophin receptor p75. Science 304, 870–875 (2004). [DOI] [PubMed] [Google Scholar]
- 12.Gong Y., Cao P., Yu H. J., Jiang T., Crystal structure of the neurotrophin-3 and p75NTR symmetrical complex. Nature 454, 789–793 (2008). [DOI] [PubMed] [Google Scholar]
- 13.Yaar M., et al. , Amyloid beta binds trimers as well as monomers of the 75-kDa neurotrophin receptor and activates receptor signaling. J. Biol. Chem. 277, 7720–7725 (2002). [DOI] [PubMed] [Google Scholar]
- 14.Wang K. C., Kim J. A., Sivasankaran R., Segal R., He Z., P75 interacts with the Nogo receptor as a co-receptor for Nogo, MAG and OMgp. Nature 420, 74–78 (2002). [DOI] [PubMed] [Google Scholar]
- 15.Zanin J. P., Abercrombie E., Friedman W. J., Proneurotrophin-3 promotes cell cycle withdrawal of developing cerebellar granule cell progenitors via the p75 neurotrophin receptor. eLife 5, e16654 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Langevin C., Jaaro H., Bressanelli S., Fainzilber M., Tuffereau C., Rabies virus glycoprotein (RVG) is a trimeric ligand for the N-terminal cysteine-rich domain of the mammalian p75 neurotrophin receptor. J. Biol. Chem. 277, 37655–37662 (2002). [DOI] [PubMed] [Google Scholar]
- 17.Vilar M., et al. , Activation of the p75 neurotrophin receptor through conformational rearrangement of disulphide-linked receptor dimers. Neuron 62, 72–83 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18.Tanaka K., Kelly C. E., Goh K. Y., Lim K. B., Ibáñez C. F., Death domain signaling by disulfide-linked dimers of the p75 neurotrophin receptor mediates neuronal death in the CNS. J. Neurosci. 36, 5587–5595 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19.Mineev K. S., Goncharuk S. A., Kuzmichev P. K., Vilar M., Arseniev A. S., NMR dynamics of transmembrane and intracellular domains of p75NTR in lipid-protein nanodiscs. Biophys. J. 109, 772–782 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Anastasia A., Barker P. A., Chao M. V., Hempstead B. L., Detection of p75NTR trimers: Implications for receptor stoichiometry and activation. J. Neurosci. 35, 11911–11920 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21.Marchetti L., et al. , Ligand signature in the membrane dynamics of single TrkA receptor molecules. J. Cell Sci. 126, 4445–4456 (2013). [DOI] [PubMed] [Google Scholar]
- 22.De Nadai T., et al. , Precursor and mature NGF live tracking: One versus many at a time in the axons. Sci. Rep. 6, 20272 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23.Marchetti L., et al. , Site-specific labeling of neurotrophins and their receptors via short and versatile peptide tags. PLoS One 9, e113708 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Gobbo F., Bonsignore F., Amodeo R., Cattaneo A., Marchetti L., Site-specific direct labeling of neurotrophins and their receptors: From biochemistry to advanced imaging applications. Methods Mol. Biol. 1727, 295–314 (2018). [DOI] [PubMed] [Google Scholar]
- 25.Callegari A., et al. , Single particle tracking of acyl carrier protein (ACP)-tagged TrkA receptors in PC12nnr5 cells. J. Neurosci. Methods 204, 82–86 (2012). [DOI] [PubMed] [Google Scholar]
- 26.Schachtrup C., et al. , Nuclear pore complex remodeling by p75(NTR) cleavage controls TGF-β signaling and astrocyte functions. Nat. Neurosci. 18, 1077–1080 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27.Underwood C. K., Reid K., May L. M., Bartlett P. F., Coulson E. J., Palmitoylation of the C-terminal fragment of p75(NTR) regulates death signaling and is required for subsequent cleavage by gamma-secretase. Mol. Cell. Neurosci. 37, 346–358 (2008). [DOI] [PubMed] [Google Scholar]
- 28.Zuccaro E., et al. , Polarized expression of p75(NTR) specifies axons during development and adult neurogenesis. Cell Rep. 7, 138–152 (2014). [DOI] [PubMed] [Google Scholar]
- 29.Deinhardt K., et al. , Neuronal growth cone retraction relies on proneurotrophin receptor signaling through Rac. Sci. Signal. 4, ra82 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30.Lee K. F., et al. , Targeted mutation of the gene encoding the low affinity NGF receptor p75 leads to deficits in the peripheral sensory nervous system. Cell 69, 737–749 (1992). [DOI] [PubMed] [Google Scholar]
- 31.Costantini C., Weindruch R., Della Valle G., Puglielli L., A TrkA-to-p75NTR molecular switch activates amyloid beta-peptide generation during aging. Biochem. J. 391, 59–67 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32.Jaqaman K., et al. , Cytoskeletal control of CD36 diffusion promotes its receptor and signaling function. Cell 146, 593–606 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33.Youker R. T., et al. , Multiple motifs regulate apical sorting of p75 via a mechanism that involves dimerization and higher-order oligomerization. Mol. Biol. Cell 24, 1996–2007 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Brooks A. J., et al. , Mechanism of activation of protein kinase JAK2 by the growth hormone receptor. Science 344, 1249783 (2014). [DOI] [PubMed] [Google Scholar]
- 35.Chung I., et al. , Spatial control of EGF receptor activation by reversible dimerization on living cells. Nature 464, 783–787 (2010). [DOI] [PubMed] [Google Scholar]
- 36.Kasai R. S., Kusumi A., Single-molecule imaging revealed dynamic GPCR dimerization. Curr. Opin. Cell Biol. 27, 78–86 (2014). [DOI] [PubMed] [Google Scholar]
- 37.Zhang W., et al. , Single-molecule imaging reveals transforming growth factor-β-induced type II receptor dimerization. Proc. Natl. Acad. Sci. U.S.A. 106, 15679–15683 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38.Sykes A. M., et al. , The effects of transmembrane sequence and dimerization on cleavage of the p75 neurotrophin receptor by γ-secretase. J. Biol. Chem. 287, 43810–43824 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39.Simons K., Sampaio J. L., Membrane organization and lipid rafts. Cold Spring Harb. Perspect. Biol. 3, a004697 (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Korade Z., Kenworthy A. K., Lipid rafts, cholesterol, and the brain. Neuropharmacology 55, 1265–1273 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Bronfman F. C., Lazo O. M., Flores C., Escudero C. A., Spatiotemporal intracellular dynamics of neurotrophin and its receptors. Implications for neurotrophin signaling and neuronal function. Handb. Exp. Pharmacol. 220, 33–65 (2015). [DOI] [PubMed] [Google Scholar]
- 42.Dekkers M. P. J., Nikoletopoulou V., Barde Y. A., Cell biology in neuroscience: Death of developing neurons: New insights and implications for connectivity. J. Cell Biol. 203, 385–393 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43.Day C. A., Kenworthy A. K., Tracking microdomain dynamics in cell membranes. Biochim. Biophys. Acta Biomembr. 1788, 245–253 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44.Zhang Y. H., Khanna R., Nicol G. D., Nerve growth factor/p75 neurotrophin receptor-mediated sensitization of rat sensory neurons depends on membrane cholesterol. Neuroscience 248, 562–570 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45.Huang C. S., et al. , Nerve growth factor signaling in caveolae-like domains at the plasma membrane. J. Biol. Chem. 274, 36707–36714 (1999). [DOI] [PubMed] [Google Scholar]
- 46.Pinaud F., et al. , Dynamic partitioning of a glycosyl-phosphatidylinositol-anchored protein in glycosphingolipid-rich microdomains imaged by single-quantum dot tracking. Traffic 10, 691–712 (2009). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47.Komura N., et al. , Raft-based interactions of gangliosides with a GPI-anchored receptor. Nat. Chem. Biol. 12, 402–410 (2016). [DOI] [PubMed] [Google Scholar]
- 48.Frade J. M., Rodríguez-Tébar A., Barde Y. A., Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature 383, 166–168 (1996). [DOI] [PubMed] [Google Scholar]
- 49.Bamji S. X., et al. , The p75 neurotrophin receptor mediates neuronal apoptosis and is essential for naturally occurring sympathetic neuron death. J. Cell Biol. 140, 911–923 (1998). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50.Zagrebelsky M., et al. , The p75 neurotrophin receptor negatively modulates dendrite complexity and spine density in hippocampal neurons. J. Neurosci. 25, 9989–9999 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51.Cognet L., Lounis B., Choquet D., Tracking receptors using individual fluorescent and nonfluorescent nanolabels. Cold Spring Harb. Protoc. 2014, 207–213 (2014). [DOI] [PubMed] [Google Scholar]
- 52.Yamashita T., Higuchi H., Tohyama M., The p75 receptor transduces the signal from myelin-associated glycoprotein to Rho. J. Cell Biol. 157, 565–570 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53.Lewis A. K., et al. , Death receptor 5 networks require membrane cholesterol for proper structure and function. J. Mol. Biol. 428, 4843–4855 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 54.Dijkman P. M., et al. , Dynamic tuneable G protein-coupled receptor monomer-dimer populations. Nat. Commun. 9, 1710 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 55.Mehlen P., Thibert C., Dependence receptors: Between life and death. Cell. Mol. Life Sci. 61, 1854–1866 (2004). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56.Nadezhdin K. D., et al. , Structural basis of p75 transmembrane domain dimerization. J. Biol. Chem. 291, 12346–12357 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 57.Lim Y. S., et al. , p75(NTR) mediates ephrin-A reverse signaling required for axon repulsion and mapping. Neuron 59, 746–758 (2008). [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58.Glerup S., et al. , SorCS2 regulates dopaminergic wiring and is processed into an apoptotic two-chain receptor in peripheral glia. Neuron 82, 1074–1087 (2014). [DOI] [PubMed] [Google Scholar]
- 59.Dhanoa N. K., Krol K. M., Jahed A., Crutcher K. A., Kawaja M. D., Null mutations for exon III and exon IV of the p75 neurotrophin receptor gene enhance sympathetic sprouting in response to elevated levels of nerve growth factor in transgenic mice. Exp. Neurol. 198, 416–426 (2006). [DOI] [PubMed] [Google Scholar]
- 60.Zahavi E. E., et al. , The receptor tyrosine kinase TrkB signals without dimerization at the plasma membrane. Sci. Signal. 11, eaao4006 (2018). [DOI] [PubMed] [Google Scholar]
- 61.Covaceuszach S., et al. , The conundrum of the high-affinity NGF binding site formation unveiled? Biophys. J. 108, 687–697 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.